Skip to main content

Table 5 Correlation between hsa-miR-182-5p (miR-182) and target genes in patients with ovarian cancer(n = 376)

From: Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis

miRNATarget generp-valueFDR
hsa-miR-182-5pTPM1−0.1435.61E-031.99E-02
hsa-miR-182-5pCOL1A1−0.1542.74E-031.14E-02
hsa-miR-182-5pPDGFRA−0.184.40E-042.87E-03
hsa-miR-182-5pUBE2B−0.1493.87E-031.49E-02
hsa-miR-182-5pMEF2C−0.2018.70E-058.01E-04
hsa-miR-182-5pSNAI2−0.1542.84E-031.18E-02
hsa-miR-182-5pCACNA2D1−0.1044.44E-021.01E-01
hsa-miR-182-5pRECK−0.1532.93E-031.21E-02
hsa-miR-182-5pFOXO1−0.1152.57E-026.58E-02
hsa-miR-182-5pFBN1−0.1396.81E-032.33E-02
hsa-miR-182-5pANTXR2−0.1872.62E-041.90E-03
hsa-miR-182-5pNKX3–1−0.1368.32E-032.70E-02
hsa-miR-182-5pTIMP2−0.1941.51E-041.23E-03
hsa-miR-182-5pAKT3−0.2056.28E-056.32E-04
hsa-miR-182-5pRBPMS−0.179.57E-045.21E-03
hsa-miR-182-5pEGLN3−0.1132.83E-027.09E-02
hsa-miR-182-5pDERL1−0.1641.41E-036.98E-03
hsa-miR-182-5pPRKD1−0.1775.57E-043.44E-03
hsa-miR-182-5pSLC2A13−0.1152.57E-026.58E-02
hsa-miR-182-5pMAF−0.2681.26E-075.19E-06
hsa-miR-182-5pDCN−0.2363.68E-066.45E-05
  1. miRNA or miR, microRNA, FDR false discovery rate